Sagimet Biosciences (SGMT) Times Interest Earned (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Times Interest Earned of -$5.88 for Q1 2026, up 99.23% year-over-year from -$2.95 in Q1 2025, and down 107.4% quarter-over-quarter from -$2.83 in Q4 2025.
Sagimet Biosciences (SGMT) Times Interest Earned (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$5.88 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 99.23% year-over-year to -$5.88; the TTM figure through Mar 2026 stood at -$24.45 (up 99.03% YoY), while the FY2025 annual figure was -$14.97, down 1725.74% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$5.88, down from -$2.83 in the prior quarter.
- The five-year high for Times Interest Earned was -$0.15 in Q4 2022, with the low at -$1183.2 in Q4 2023.
- The 5-year median for Times Interest Earned is -$2.43 (2025), against an average of -$271.03.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned slumped 766001.52% in 2023, then surged 99.98% in 2024.
- Sagimet Biosciences' Times Interest Earned stood at -$0.15 in 2022, then plunged by 766001.52% to -$1183.2 in 2023, then soared by 99.98% to -$0.27 in 2024, then sank by 933.96% to -$2.83 in 2025, then tumbled by 107.4% to -$5.88 in 2026.
- Business Quant data shows SGMT's Times Interest Earned at -$5.88 in Q1 2026, -$2.83 in Q4 2025, and -$2.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | -1.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.14 |
| Mar 31, 2026 | -5.88 |
| Dec 31, 2025 | -2.83 |
| Sep 30, 2025 | -2.03 |
| Jun 30, 2025 | -1.11 |
| Mar 31, 2025 | -764.04 |
| Dec 31, 2024 | -0.27 |
| Jun 30, 2024 | -196.09 |
| Mar 31, 2024 | -1,096.00 |
| Dec 31, 2023 | -1,183.25 |
| Sep 30, 2023 | -0.42 |
| Jun 30, 2023 | -0.33 |
| Dec 31, 2022 | -0.15 |